AR007493A1 - Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica - Google Patents

Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica

Info

Publication number
AR007493A1
AR007493A1 ARP970101333A ARP970101333A AR007493A1 AR 007493 A1 AR007493 A1 AR 007493A1 AR P970101333 A ARP970101333 A AR P970101333A AR P970101333 A ARP970101333 A AR P970101333A AR 007493 A1 AR007493 A1 AR 007493A1
Authority
AR
Argentina
Prior art keywords
spray dried
genetic therapy
dried microparticles
therapeutic vehicles
microparticles
Prior art date
Application number
ARP970101333A
Other languages
English (en)
Spanish (es)
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of AR007493A1 publication Critical patent/AR007493A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP970101333A 1996-04-03 1997-04-03 Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica AR007493A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9607035.4A GB9607035D0 (en) 1996-04-03 1996-04-03 Spray-dried microparticles as therapeutic vehicles
GB9601379 1996-06-07

Publications (1)

Publication Number Publication Date
AR007493A1 true AR007493A1 (es) 1999-11-10

Family

ID=26308516

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101333A AR007493A1 (es) 1996-04-03 1997-04-03 Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica

Country Status (14)

Country Link
EP (1) EP0936902B1 (OSRAM)
JP (1) JP2000507568A (OSRAM)
AR (1) AR007493A1 (OSRAM)
AT (1) ATE243027T1 (OSRAM)
AU (1) AU715512B2 (OSRAM)
CA (1) CA2250478A1 (OSRAM)
DE (1) DE69722952T2 (OSRAM)
DK (1) DK0936902T3 (OSRAM)
ES (1) ES2201283T3 (OSRAM)
GB (1) GB9607035D0 (OSRAM)
NO (1) NO984462L (OSRAM)
PT (1) PT936902E (OSRAM)
WO (1) WO1997036578A1 (OSRAM)
ZA (1) ZA972837B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
ATE192334T1 (de) 1995-11-09 2000-05-15 Microbiological Res Authority Mikroverkapselte dna zur impfung und gentherapie
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
WO2005112885A2 (en) 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
EP1765294B1 (en) 2004-05-12 2008-09-24 Baxter International Inc. Nucleic acid microspheres, production and delivery thereof
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
AU2007281737B2 (en) 2006-08-04 2013-09-19 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US8808747B2 (en) 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
CA3107055A1 (en) * 2018-07-23 2020-01-30 Translate Bio, Inc. Dry powder formulations for messenger rna
US20220096375A1 (en) * 2019-01-09 2022-03-31 Ziccum Ab Stabilized non-enveloped virus compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
CA2115444C (en) * 1992-06-12 2000-10-03 Yuji Makino Preparation for intratracheobronchial administration
AU659328B2 (en) * 1992-06-12 1995-05-11 Teijin Limited Ultrafine powder for inhalation and production thereof
NZ265555A (en) * 1993-04-19 1997-09-22 Medisorb Technologies Internat Biodegradable microparticle compositions of antisense oligodeoxyribonucleotides
EP0759939B1 (en) * 1994-05-18 2005-07-20 Nektar Therapeutics Methods and compositions for the dry powder formulation of interferons
FI971332L (fi) * 1994-09-29 1997-04-01 Andaris Ltd Suihkukuivatut mikropartikkelit terapeuttisina vehikkeleinä
AU5417796A (en) * 1995-03-07 1996-09-23 University Of Pittsburgh A dry powder formulation for gene therapy
CA2227287A1 (en) * 1995-07-21 1997-02-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles

Also Published As

Publication number Publication date
DE69722952T2 (de) 2003-12-11
NO984462D0 (no) 1998-09-25
CA2250478A1 (en) 1997-10-09
ATE243027T1 (de) 2003-07-15
GB9607035D0 (en) 1996-06-05
NO984462L (no) 1998-09-25
DK0936902T3 (da) 2003-10-06
EP0936902B1 (en) 2003-06-18
AU2302097A (en) 1997-10-22
ZA972837B (en) 1998-04-03
PT936902E (pt) 2003-11-28
WO1997036578A1 (en) 1997-10-09
EP0936902A1 (en) 1999-08-25
JP2000507568A (ja) 2000-06-20
ES2201283T3 (es) 2004-03-16
AU715512B2 (en) 2000-02-03
DE69722952D1 (de) 2003-07-24

Similar Documents

Publication Publication Date Title
AR007493A1 (es) Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica
MX9702357A (es) Microparticulas secadas por aspersion como vehiculos terapeuticos.
GB2231495A (en) Enhanced uptake drug delivery system
ES2195408T3 (es) Microparticulas perforadas y procedimientos de uso.
DE69533128D1 (de) Pharmazeutische akzeptabel dnase zusammensetzung
WO2003024396A3 (en) Dry powder medicament formulations
BR9510210A (pt) Dispositivo de inalação e processo para dispersão de uma substância farmaceuticamente ativa em uma câmara de dispersão e para administração de uma dose de uma substância farmaceuticamente ativa em pó
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
BR9607490B8 (pt) pó para uso em inaladores de pó seco e partículas para o uso no mesmo.
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
NO934315D0 (no) Farmas!ytisk b{rer
GB9606677D0 (en) Process and device
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
PT1010688E (pt) 2-fenil-1-(3,4-di-hidroxi-5-nitrofenil)-1-etanonas substituidas seu uso no tratamento de algumas perturbacoes do sistema nervoso central e periferico e formulacoes do sistema nervoso central e periferico e formulacoes farmaceuticas que as contem
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
BR9814924A (pt) Microgrânulos de omeprazol, processo de preparação dos mesmos, e, preparações farmacêuticas
DK1107737T3 (da) Mikropartikler til anvendelse ved nålelös injektion
TR200002683T1 (tr) Bir protein ilaç veya antijen içeren lipofilik mikropartiküller ve bunları içeren formülasyon
BR0212857A (pt) Formulações e uso destas
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
NL300330I1 (nl) Preparaat voor het afgeven van peptiden
BR9809284A (pt) Construto e processo para expressão de polinucleotìdeo em altos nìveis
BR9813514A (pt) Agente para tratamento de fibras queratìnicas
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia

Legal Events

Date Code Title Description
FA Abandonment or withdrawal